|
1
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar
|
|
2
|
Robertson AG, Kim J, Al-Ahmadie H,
Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA,
Akbani R, et al: comprehensive molecular characterization of
muscle-invasive bladder cancer. Cell. 171:540–556.e25. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamat AM, Hahn NM, Efstathiou JA, Lerner
SP, Malmström PU, Choi W, Guo CC, Lotan Y and Kassouf W: Bladder
cancer. Lancet. 388:2796–2810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ebrahimi H, Amini E, Pishgar F, Moghaddam
SS, Nabavizadeh B, Rostamabadi Y, Aminorroaya A, Fitzmaurice C,
Farzadfar F, Nowroozi MR, et al: Global, regional and national
burden of bladder cancer, 1990 to 2016: Results from the GBD study
2016. J Urol. 201:893–901. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bai Y, Cui W, Xin Y, Miao X, Barati MT,
Zhang C, Chen Q, Tan Y, Cui T, Zheng Y and Cai L: Prevention by
sulforaphane of diabetic cardiomyopathy is associated with
up-regulation of Nrf2 expression and transcription activation. J
Mol Cell Cardiol. 57:82–95. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang G, Nie JH, Bao Y and Yang X:
Sulforaphane rescues ethanol-suppressed angiogenesis through
oxidative and endoplasmic reticulum stress in chick embryos. J
Agric Food Chem. 66:9522–9533. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu P, Atkinson SJ, Akbareian SE, Zhou Z,
Munsterberg A, Robinson SD and Bao Y: Sulforaphane exerts
anti-angiogenesis effects against hepatocellular carcinoma through
inhibition of STAT3/HIF-1α/VEGF signalling. Sci Rep. 7:126512017.
View Article : Google Scholar
|
|
8
|
Russo M, Spagnuolo C, Russo GL,
Skalicka-Woźniak K, Daglia M, Sobarzo-Sánchez E, Nabavi SF and
Nabavi SM: Nrf2 targeting by sulforaphane: A potential therapy for
cancer treatment. Crit Rev Food Sci Nutr. 58:1391–1405. 2018.
View Article : Google Scholar
|
|
9
|
McMahon M, Itoh K, Yamamoto M and Hayes
JD: Keap1-dependent proteasomal degradation of transcription factor
Nrf2 contributes to the negative regulation of antioxidant response
element-driven gene expression. J Biol Chem. 278:21592–21600. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeong WS, Keum YS, Chen C, Jain MR, Shen
G, Kim JH, Li W and Kong AN: Differential expression and stability
of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural
chemopreventive compounds in HepG2 human hepatoma cells. J Biochem
Mol Biol. 38:167–176. 2005.PubMed/NCBI
|
|
11
|
Choi S and Singh SV: Bax and Bak are
required for apoptosis induction by sulforaphane, a cruciferous
vegetable-derived cancer chemopreventive agent. Cancer Res.
65:2035–2043. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yeh CT and Yen GC: Effect of sulforaphane
on metallothionein expression and induction of apoptosis in human
hepatoma HepG2 cells. Carcinogenesis. 26:2138–2148. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu R, Kim BR, Chen C, Hebbar V and Kong
AN: The roles of JNK and apoptotic signaling pathways in
PEITC-mediated responses in human HT-29 colon adenocarcinoma cells.
Carcinogenesis. 24:1361–1367. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu ZM, Chen GG, Ng EK, Leung WK, Sung JJ
and Chung SC: Upregulation of heme oxygenase-1 and p21 confers
resistance to apoptosis in human gastric cancer cells. Oncogene.
23:503–513. 2004. View Article : Google Scholar
|
|
15
|
Gamet-Payrastre L, Lumeau S, Gasc N,
Cassar G, Rollin P and Tulliez J: Selective cytostatic and
cytotoxic effects of glucosinolates hydrolysis products on human
colon cancer cells in vitro. Anticancer Drugs. 9:141–148. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Islam SS, Mokhtari RB, Akbari P, Hatina J,
Yeger H and Farhat WA: Simultaneous targeting of bladder tumor
growth, survival, and epithelial-to-mesenchymal transition with a
novel therapeutic combination of acetazolamide (AZ) and
sulforaphane (SFN). Target Onco. 11:209–227. 2016. View Article : Google Scholar
|
|
17
|
Jo GH, Kim GY, Kim WJ, Park KY and Choi
YH: Sulforaphane induces apoptosis in T24 human urinary bladder
cancer cells through a reactive oxygen species-mediated
mitochondrial pathway: the involvement of endoplasmic reticulum
stress and the Nrf2 signaling pathway. Int J Oncol. 45:1497–1506.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park HS, Han MH, Kim GY, Moon SK, Kim WJ,
Hwang HJ, Park KY and Choi YH: Sulforaphane induces reactive oxygen
species-mediated mitotic arrest and subsequent apoptosis in human
bladder cancer 5637 cells. Food Chem Toxicol. 64:157–165. 2014.
View Article : Google Scholar
|
|
19
|
Wang S, Zhao X, Yang S, Chen B and Shi J:
Salidroside alleviates high glucose-induced oxidative stress and
extracellular matrix accumulation in rat glomerular mesangial cells
by the TXNIP-NLRP3 inflammasome pathway. Chem Biol Interact.
278:48–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Srivastava C, Irshad K, Dikshit B,
Chattopadhyay P, Sarkar C, Gupta DK, Sinha S and Chosdol K: FAT1
modulates EMT and stemness genes expression in hypoxic
glioblastoma. Int J Cancer. 142:805–812. 2018. View Article : Google Scholar
|
|
21
|
Hu X, Zhai Y, Shi R, Qian Y, Cui H, Yang
J, Bi Y, Yan T, Yang J, Ma Y, et al: FAT1 inhibits cell migration
and invasion by affecting cellular mechanical properties in
esophageal squamous cell carcinoma. Oncol Rep. 39:2136–2146.
2018.PubMed/NCBI
|
|
22
|
Dikshit B, Irshad K, Madan E, Aggarwal N,
Sarkar C, Chandra PS, Gupta DK, Chattopadhyay P, Sinha S and
Chosdol K: FAT1 acts as an upstream regulator of oncogenic and
inflammatory pathways, via PDCD4, in glioma cells. Oncogene.
32:3798–3808. 2013. View Article : Google Scholar
|
|
23
|
Cazier JB, Rao SR, McLean CM, Walker AK,
Wright BJ, Jaeger EE, Kartsonaki C, Marsden L, Yau C, Camps C, et
al: Whole-genome sequencing of bladder cancers reveals somatic
CDKN1A mutations and clinicopathological associations with mutation
burden. Nat Commun. 5:37562014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Ranjit M, Motomura K, Ohka F, Wakabayashi
T and Natsume A: Applicable advances in the molecular pathology of
glioblastoma. Brain Tumor Pathol. 32:153–162. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kan SF, Wang J and Sun GX: Sulforaphane
regulates apoptosis- and proliferation-related signaling pathways
and synergizes with cisplatin to suppress human ovarian cancer. Int
J Mol Med. 42:2447–2458. 2018.PubMed/NCBI
|
|
27
|
Choi YH: ROS-mediated activation of AMPK
plays a critical role in sulforaphane-induced apoptosis and mitotic
arrest in AGS human gastric cancer cells. Gen Physiol Biophys.
37:129–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang DX, Zou YJ, Zhuang XB, Chen SX, Lin
Y, Li WL, Lin JJ and In ZQ: Sulforaphane suppresses EMT and
metastasis in human lung cancer through miR-616-5p-mediated
GSK3β/β-catenin signaling pathways. Acta Pharmacol Sin. 38:241–251.
2017. View Article : Google Scholar
|
|
29
|
Lin SC, Lin LH, Yu SY, Kao SY, Chang KW,
Cheng HW and Liu CJ: FAT1 somatic mutations in head and neck
carcinoma are associated with tumor progression and survival.
Carcinogenesis. 39:1320–1330. 2018.PubMed/NCBI
|
|
30
|
Hayes TF, Benaich N, Goldie SJ, Sipilä K,
Ames-Draycott A, Cai W, Yin G and Watt FM: Integrative genomic and
functional analysis of human oral squamous cell carcinoma cell
lines reveals synergistic effects of FAT1 and CASP8 inactivation.
Cancer Lett. 383:106–114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pileri P, Campagnoli S, Grandi A, Parri M,
De Camilli E, Song C, Ganfini L, Lacombe A, Naldi I, Sarmientos P,
et al: FAT1: A potential target for monoclonal antibody therapy in
colon cancer. Br J Cancer. 115:40–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kranz D and Boutros M: A synthetic lethal
screen identifies FAT1 as an antagonist of caspase-8 in extrinsic
apoptosis. EMBO J. 33:181–197. 2014.PubMed/NCBI
|
|
33
|
Shan Y, Zhang L, Bao Y, Li B, He C, Gao M,
Feng X, Xu W, Zhang X and Wang S: Epithelial-mesenchymal
transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail,
ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. J
Nutr Biochem. 24:1062–1069. 2013. View Article : Google Scholar
|
|
34
|
Ahmed AF, de Bock CE, Sontag E,
Hondermarck H, Lincz LF and Thorne RF: FAT1 cadherin controls
neuritogenesis during NTera2 cell differentiation. Biochem Biophys
Res Commun. 514:625–631. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martin D, Degese MS, Vitale-Cross L,
Iglesias-Bartolome R, Valera JLC, Wang Z, Feng X, Yeerna H, Vadmal
V, Moroishi T, et al: Assembly and activation of the Hippo
signalome by FAT1 tumor suppressor. Nat Commun. 9:23722018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alamoud KA and Kukuruzinska MA: Emerging
insights into Wnt/β-catenin signaling in head and neck cancer. J
Dent Res. 97:665–673. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu X, Zhai Y, Kong P, Cui H, Yan T, Yang
J, Qian Y, Ma Y, Wang F, Li H, et al: FAT1 prevents epithelial
mesenchymal transition (EMT) via MAPK/ERK signaling pathway in
esophageal squamous cell cancer. Cancer Lett. 397:83–93. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grifantini R, Taranta M, Gherardini L,
Naldi I, Parri M, Grandi A, Giannetti A, Tombelli S, Lucarini G,
Ricotti L, et al: Magnetically driven drug delivery systems
improving targeted immunotherapy for colon-rectal cancer. J Control
Release. 280:76–86. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Z, Li C, Shang L, Zhang Y, Zou R,
Zhan Y and Bi B: Sulforaphane induces apoptosis and inhibits
invasion in U251MG glioblastoma cells. Springerplus. 5:2352016.
View Article : Google Scholar : PubMed/NCBI
|
